All In MedTech

FDA Clearance Tracker · P080012-S040

Prometra Programmable Infusion Pump System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 28, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 28, 2019

Approved

Time to decision

656 days

Received Apr 12, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P080012-S040
Device name
Prometra Programmable Infusion Pump System
Applicant location
Hackettstown, NJ
Received
Apr 12, 2017
Decided
Jan 28, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080012

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

Approval for updates to the hardware (Clinician Programmer Model #13828), software and labeling of the Clinician Programmer and modifications to the software and labeling of the Patient Therapy Controller (PTC) for the Prometra Programmable Infusion Pump System.

Source documents

Other decisions for Infusyn Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.